Ye Xu

ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 7

Top Venues

Cancer science

Breast cancer research and treatment

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Familial cancer

Mayo Clinic Arizona

Peking University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mayo Clinic Arizona

United States

Visiting scientist

Peking University Cancer Hospital

China

Associate Professor :: Breast Center

Education History

Peking University

China

PHD

Publications

Jie Sun, Futao Chu, Jia-Ni Pan, Yaxin Zhang, Lu Yao, Jiuan Chen, Li Hu, Juan Zhang, Ye Xu, Xiao-Jia Wang, Wen-Ming Cao, Yuntao Xie
BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model for BRCA Carriers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Qiting Wan, Li Hu, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Ye Xu, Yuntao Xie
Clinical phenotypes combined with saturation genome editing identifying the pathogenicity of BRCA1 variants of uncertain significance in breast cancer. Familial cancer 20 (2) (2020)
Zhenhua Fan, Li Hu, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Ye Xu, Yuntao Xie
Germline mutation in DNA-repair genes is associated with poor survival in BRCA1/2-negative breast cancer patients. Cancer science 110 (10) (2019)
Yifan Wu, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Ye Xu, Yuntao Xie
Spectrum and clinical relevance of PALB2 germline mutations in 7657 Chinese BRCA1/2-negative breast cancer patients. Breast cancer research and treatment 179 (3) (2019)
Zhenhua Fan, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Ye Xu, Yuntao Xie
Identification and analysis of CHEK2 germline mutations in Chinese BRCA1/2-negative breast cancer patients. Breast cancer research and treatment 169 (1) (2018)
Tonghui Wang, Ye Xu, Shuyan Sheng, Hua Yuan, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Yuntao Xie
HER2 somatic mutations are associated with poor survival in HER2-negative breast cancers. Cancer science 108 (4) (2017)
Ye Xu, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Yuntao Xie
Predictive value of BRCA1/2 mRNA expression for response to neoadjuvant chemotherapy in BRCA-negative breast cancers. Cancer science 109 (1) (2017)

Ye Xu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ye Xu